The company's principal activities are to research and develop innovative drug candidates. Innovative drug candidates are used for the treatment of central nervous system conditions that exhibit impairment of memory and other cognitive functions. The central nervous system therapies are designed to address biological targets within the cellular pathways. These are involved in memory formation and other cognitive functions. It currently has four clinical and preclinical drug candidates and also multiple drug discovery programs in development. The company operates in the domestic market.
